Emerging Therapeutic Biomarkers in Endometrial Cancer
Peixin Dong(Hokkaido University of Science), Noriaki Sakuragi(Hokkaido University), Hidemichi Watari(Hokkaido University of Science), Yosuke Konno(Hokkaido University of Science), Masanori Kaneuchi(Sapporo University), Satoko Sudo(Sapporo University)
Cited by 55
Related Papers
Apoptosis and Molecular Targeting Therapy in Cancer
|BioMed Research International|2014|1.1k
Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis
|Oncogene|2012|305
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
|Cancer Research|2016|178
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
|Journal of Experimental & Clinical Cancer Research|2019|164